Literature DB >> 12915501

Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987.

Wolfgang Koenig1, Malte Sund, Margit Fröhlich, Hannelore Löwel, Winston L Hutchinson, Mark B Pepys.   

Abstract

The authors sought to assess the repeatability of measurements of C-reactive protein, an independent predictor of coronary heart disease, in a large cohort of apparently healthy men and to correct earlier estimates of the association of C-reactive protein and coronary heart disease for the measurement error in this protein. They measured C-reactive protein by a high-sensitivity assay in 936 men aged 45-64 years in the MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease) Augsburg cohort in 1984-1985 and remeasured it 3 years later. All men were subjected to an 8-year follow-up of their cardiovascular status. The analytical variation of the assay was small, with the analytical variance component at 1 percent of the within-subject variance component, a repeatability coefficient of 25 percent, and a reliability coefficient of 1.00. In contrast, the within-subject variation of C-reactive protein corresponded to a repeatability coefficient of 740 percent and a reliability coefficient of 0.54, indicating considerable within-subject variation. Based on the authors' estimates, three serial determinations of C-reactive protein should be done to achieve a reliability of 0.75, the value they found for total cholesterol. Correcting the hazard ratios in their original analysis of the association of coronary heart disease and high-sensitivity-assay C-reactive protein for the measurement error in C-reactive protein and covariables leads to a considerably larger estimate. The results suggest that the true association between C-reactive protein and cardiovascular risk is underestimated by a single C-reactive protein determination, and that several serial C-reactive protein measurements should be taken.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915501     DOI: 10.1093/aje/kwg135

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  39 in total

1.  Trajectories of peripheral interleukin-6, structure of the hippocampus, and cognitive impairment over 14 years in older adults.

Authors:  Andrea L Metti; Howard Aizenstein; Kristine Yaffe; Robert M Boudreau; Anne Newman; Lenore Launer; Peter J Gianaros; Oscar L Lopez; Judith Saxton; Diane G Ives; Stephen Kritchevsky; Abbe N Vallejo; Caterina Rosano
Journal:  Neurobiol Aging       Date:  2015-07-28       Impact factor: 4.673

2.  The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study.

Authors:  Keenan A Walker; B Gwen Windham; Charles H Brown; David S Knopman; Clifford R Jack; Thomas H Mosley; Elizabeth Selvin; Dean F Wong; Timothy M Hughes; Yun Zhou; Alden L Gross; Rebecca F Gottesman
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia.

Authors:  Riccardo E Marioni; Marlene C Stewart; Gordon D Murray; Ian J Deary; F Gerry R Fowkes; Gordon D O Lowe; Ann Rumley; Jackie F Price
Journal:  Psychosom Med       Date:  2009-08-06       Impact factor: 4.312

4.  Occupational vehicle-related particulate exposure and inflammatory markers in trucking industry workers.

Authors:  Yueh-Hsiu Mathilda Chiu; Eric Garshick; Jaime E Hart; Donna Spiegelman; Douglas W Dockery; Thomas J Smith; Francine Laden
Journal:  Environ Res       Date:  2016-04-19       Impact factor: 6.498

5.  Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort.

Authors:  Theodore M Brasky; John D Potter; Alan R Kristal; Ruth E Patterson; Ulrike Peters; Maryam M Asgari; Mark D Thornquist; Emily White
Journal:  Cancer Causes Control       Date:  2012-01-03       Impact factor: 2.506

Review 6.  Monitoring of inflammation in patients on dialysis: forewarned is forearmed.

Authors:  Christiaan L Meuwese; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2011-03       Impact factor: 28.314

7.  Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study.

Authors:  Leah H Rubin; Lorie Benning; Sheila M Keating; Philip J Norris; Jane Burke-Miller; Antonia Savarese; Krithika N Kumanan; Saria Awadalla; Gayle Springer; Kathyrn Anastos; Mary Young; Joel Milam; Victor G Valcour; Kathleen M Weber; Pauline M Maki
Journal:  J Neurovirol       Date:  2017-10-23       Impact factor: 2.643

8.  Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Emil M DeGoma; Benjamin French; Richard L Dunbar; Matthew A Allison; Emile R Mohler; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2012-07-20       Impact factor: 5.162

9.  Trajectories of inflammatory markers and cognitive decline over 10 years.

Authors:  Andrea L Metti; Kristine Yaffe; Robert M Boudreau; Eleanor M Simonsick; Ryan M Carnahan; Suzanne Satterfield; Tamara B Harris; Hilsa N Ayonayon; Caterina Rosano; Jane A Cauley
Journal:  Neurobiol Aging       Date:  2014-06-06       Impact factor: 4.673

10.  Three-year change in inflammatory markers in elderly people and mortality: the Invecchiare in Chianti study.

Authors:  Dawn E Alley; Eileen Crimmins; Karen Bandeen-Roche; Jack Guralnik; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2007-08-28       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.